Stanford biomedical ethicist speaks on role of race in scientific research

DENVER, Co- Is racial profiling OK in a research setting? Is categorizing groups of people based on genetic characteristics acceptable? These are some of the questions that researchers, led by Mildred Cho, PhD, senior research scholar at the Stanford Center for Biomedical Ethics, will tackle during a symposium at the annual meeting of the American Association for the Advancement of Science in Denver.

The symposium, titled "Ethical, Social and Policy Implications of Studies of Human Genetic Variation: New Issues from the Human Genome Project," begins at 10:30 a.m. EST Saturday.

Cho said the completion of the "first draft" of the human genome sequence has shifted scientists' attention to the discovery of human genetic variation. Current studies in this area include the examination of the link between genes and disease and the aim to identify genetic variations that contribute to differential effects of drugs, which could lead to the creation of drugs targeted to a specific group of people. Although studies differ in the way they catalogue variation, Cho said they all have the effect of grouping people based on genetic characteristics, often along racial lines, and that this raises ethical and social questions.

"Proponents (of using race as a research variable) assert that genetic differences and racial classification are strongly associated, and so support the use of race in the design of research and the application of its findings," Cho wrote in a recent paper in Science. "Critics cast race as a social construct and counter that putting subjects into racial groups fundamentally misrepresents human genetic variation and hinders research."

The symposium will examine these two positions in the context of current scientific studies of human genetic variation - including haplotype mapping, genetic clustering methods and pharmacogenetic studies - and will discuss these studies' implications on concepts of race and ethnicity. Cho will lead t

Contact: Michelle Brandt
Stanford University Medical Center

Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... ... for drugs, biologics, cell and gene therapies, and consumer health products, today announced ... Boston Virtual Conference & Expo, taking place between Aug. 31 – September 4, ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. ... published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the ... the history of eSource, the reasons it did not take off as quickly as ... source, the industry is moving towards capturing data electronically for clinical trials and then ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem cell therapy ... stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or ... some form of Alzheimers dementia, and the incidence continues to increase as individuals live ...
Breaking Biology Technology:
Cached News: